![]() Xencor Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs. | NETRIS Pharma NETRIS Pharma is a clinical-stage immuno-oncology company that develops targeted therapies for the treatment of cancer. | ABL Bio ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. | ![]() Rgenta Rgenta Therapeutics is a company developing RNA-targeting medicines focused on oncology and neurological disorders. | ||
Founding Date | Founding Date 2010 | Founding Date 1997 | Founding Date 2008 | Founding Date 2016 | Founding Date 2020 |
Type | Type Private | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Long Island City, US HQ | Locations Pasadena, US HQ San Diego, US | Locations Lyon, FR HQ | Locations HQ | Locations Woburn, US HQ |
Employees | Employees 1822% decrease | Employees 2604% increase | Employees 19 | Employees 615% increase | Employees 299% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 40m (over 7 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 65m (almost 8 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 83.5m | Total funding raised $ 108.4m | Total funding raised N/A | Total funding raised $ 90.8m | Total funding raised N/A |

Xencor is a clinical-stage biopharmaceutical company which focuses on discovery and development of engineered monoclonal antibodies to treat severe and life-threatening diseases with unmet medical needs.
View companyNETRIS Pharma is a clinical-stage immuno-oncology company that develops targeted therapies for the treatment of cancer.
View companyABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
View company
Rgenta Therapeutics is a company developing RNA-targeting medicines focused on oncology and neurological disorders.
View company